Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects

NCT05473533 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: PRS-220

Sponsor

Pieris Australia Pty Ltd